查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594435

无针给药市场：按技术、按应用划分 - 2025-2030 年全球预测

Needle Free Drug Delivery Device Market by Technology (Inhaler Technology, Jet Injectors, Novel Needle-Free Technologies), Application (Insulin Delivery for Diabetes, Pain Management, Pediatric Injections) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年无针给药市值为118.9亿美元，预计2024年将达137亿美元，复合年增长率为15.27%，预计到2030年将达到321.7亿美元。

无针给药装置代表了医疗技术的革命性进步，旨在消除传统针头注射带来的不适和焦虑。这些设备广泛应用于胰岛素给药、疫苗给药、疼痛管理、荷尔蒙给药等。对以患者为中心的医疗保健解决方案的需求不断增长、合规性的提高以及需要持续治疗管理的慢性病的患病率不断增加，推动了对此类创新的需求。从最终用途的角度来看，主要相关人员包括医院、诊所、家庭护理机构和寻求有效药物输送替代方案的製药公司。市场成长受到技术进步、医疗保健支出增加以及转向对患者更友善的给药系统的显着影响。值得注意的是，不断增长的老年人口以及对针刺伤害相关风险的认识也在推动市场向前发展方面发挥关键作用。然而，高昂的初始成本、技术限制和监管障碍等挑战可能会阻碍市场扩张。机会在于不断开发易于使用且具有成本效益且具有精确剂量功能的设备。透过整合整合物联网功能等数位健康技术，公司可以进行创新，以监控患者的用药依从性和治疗效果。另一个有前景的领域是研究和开发生物分解性和生物相容性材料，以使设备更具永续和可接受性。对公司的建议包括投资于强有力的研究和开发计划，与医疗保健提供者和付款人建立策略合作伙伴关係，以及全面的消费者教育计划以提高采用率。儘管市场竞争激烈且对监管变化敏感，但利用新技术并解决消费者担忧的公司可以获得显着的竞争优势。总体而言，在患者对非侵入性治疗选择和技术创新的需求的推动下，无针给药设备市场将出现动态成长。

主要市场统计
基准年[2023] 118.9亿美元
预测年份 [2024] 137亿美元
预测年份 [2030] 321.7亿美元
复合年增长率（%） 15.27%

市场动态：揭示快速发展的无针给药市场的关键市场洞察

无针给药市场正因供给与需求的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 自行将高黏度药物注入体内的需求不断增加
    • 世界性糖尿病等慢性疾病的增加
    • 人们对控制肝炎和爱滋病等感染疾病传播的兴趣日益浓厚
  • 市场限制因素
    • 与传统喷射系统相比，开发成本较高
  • 市场机会
    • 无痛给药领域技术快速进步
    • 介绍技术先进的产品，如胰岛素笔、胰岛素帮浦和其他设备
  • 市场挑战
    • 提供替代药物传输模式和所需的无菌系统维护

波特五力：驾驭无针给药市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对无针给药市场的影响

外部宏观环境因素在塑造无针给药市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解无针给药市场的竞争格局

对无针给药市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵无针给药市场供应商绩效评估

FPNV 定位矩阵是评估无针给药市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了无针给药市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，无针给药市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 自行将高黏度药物注入体内的需求不断增加
      • 糖尿病等慢性疾病在世界各地不断增加。
      • 人们越来越关注控制肝炎和爱滋病等感染疾病的传播。
    • 抑制因素
      • 与传统喷射系统相比，开发成本较高
    • 机会
      • 无痛药物转运领域技术快速进步
      • 胰岛素笔、胰岛素帮浦等先进科技产品介绍
    • 任务
      • 替代药物传递方法的可用性和所需的无菌系统的维护
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章无针给药市场：依技术分类

  • 吸入器技术
  • 喷射注射器
  • 新型无针技术
  • 口服给药系统
  • 经皮吸收贴片技术

第七章 无针给药市场：依应用分类

  • 糖尿病的胰岛素给药
  • 疼痛管理
  • 小儿注射剂
  • 疫苗递送

第八章美洲无针给药市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区无针给药市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲无针给药市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • 3M Company
  • AkraDermojet Inc
  • Antares Pharma Inc.
  • Bayer AG
  • Bioject Medical Technologies, Inc.
  • Crossject
  • Ferring BV
  • GlaxoSmithKline plc
  • Glide Pharmaceutical Technologies Ltd.
  • InjexPharma AG
  • MannKind Corporation
  • Medtronic, Inc.
  • Mika Medical Co.
  • PenJet
  • Zogenix, Inc.
Product Code: MRR-036C5CF3B48C

The Needle Free Drug Delivery Device Market was valued at USD 11.89 billion in 2023, expected to reach USD 13.70 billion in 2024, and is projected to grow at a CAGR of 15.27%, to USD 32.17 billion by 2030.

Needle-free drug delivery devices represent a revolutionary advance in medical technology, aiming to eliminate the discomfort and anxiety often associated with traditional needle-based injections. These devices have found widespread application in insulin administration, vaccine delivery, pain management, and hormone delivery. The necessity for such innovations is driven by the growing demand for patient-centric healthcare solutions, improved compliance, and the increasing prevalence of chronic diseases requiring ongoing therapeutic management. In terms of end-use, key stakeholders include hospitals, clinics, home-care settings, and pharmaceutical companies looking for effective drug delivery alternatives. Market growth is being significantly influenced by technological advancements, rising healthcare expenditure, and a shift towards more patient-friendly drug delivery systems. Notably, the increasing geriatric population and awareness about the risks associated with needle-stick injuries also play significant roles in propelling the market forward. However, challenges such as high initial costs, technical limitations, and regulatory hurdles can hinder market expansion. Opportunities lie in the continuous development of easy-to-use, cost-effective devices equipped with precise dosing capabilities. Companies can innovate by incorporating digital health technologies, such as integrated IoT features, to monitor patient adherence and treatment effectiveness. Another promising area is the research and development of biodegradable and biocompatible materials to make the devices more sustainable and acceptable. Recommendations for businesses include investment in robust R&D initiatives, strategic collaborations with healthcare providers and payers, and comprehensive consumer education programs to increase adoption rates. While the market is competitive and sensitive to regulatory changes, companies that leverage emerging technologies and address prevailing consumer concerns stand to gain a substantial competitive edge. Overall, the needle-free drug delivery device market is poised for dynamic growth fueled by patient demand for non-invasive treatment options and technological innovations.

KEY MARKET STATISTICS
Base Year [2023] USD 11.89 billion
Estimated Year [2024] USD 13.70 billion
Forecast Year [2030] USD 32.17 billion
CAGR (%) 15.27%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Needle Free Drug Delivery Device Market

The Needle Free Drug Delivery Device Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing need for self-administration of high viscous drug into the body
    • Rising number of chronic diseases such as diabetes globally
    • Growing focus to curb the spread of infectious diseases such as hepatitis and AIDS
  • Market Restraints
    • High development cost compared to conventional injection system
  • Market Opportunities
    • Rapid technological advancement in the field of pain-free drug transportation
    • Introduction of technologically advanced products such as insulin pen, insulin pump, and other devices
  • Market Challenges
    • Availability of alternative modes of drug delivery and requires sterility system maintenance

Porter's Five Forces: A Strategic Tool for Navigating the Needle Free Drug Delivery Device Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Needle Free Drug Delivery Device Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Needle Free Drug Delivery Device Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Needle Free Drug Delivery Device Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Needle Free Drug Delivery Device Market

A detailed market share analysis in the Needle Free Drug Delivery Device Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Needle Free Drug Delivery Device Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Needle Free Drug Delivery Device Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Needle Free Drug Delivery Device Market

A strategic analysis of the Needle Free Drug Delivery Device Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Needle Free Drug Delivery Device Market, highlighting leading vendors and their innovative profiles. These include 3M Company, AkraDermojet Inc, Antares Pharma Inc., Bayer AG, Bioject Medical Technologies, Inc., Crossject, Ferring B.V., GlaxoSmithKline plc, Glide Pharmaceutical Technologies Ltd., InjexPharma AG, MannKind Corporation, Medtronic, Inc., Mika Medical Co., PenJet, and Zogenix, Inc..

Market Segmentation & Coverage

This research report categorizes the Needle Free Drug Delivery Device Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Inhaler Technology, Jet Injectors, Novel Needle-Free Technologies, Oral Drug Delivery System, and Transdermal Patch Technology.
  • Based on Application, market is studied across Insulin Delivery for Diabetes, Pain Management, Pediatric Injections, and Vaccine Delivery.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing need for self-administration of high viscous drug into the body
      • 5.1.1.2. Rising number of chronic diseases such as diabetes globally
      • 5.1.1.3. Growing focus to curb the spread of infectious diseases such as hepatitis and AIDS
    • 5.1.2. Restraints
      • 5.1.2.1. High development cost compared to conventional injection system
    • 5.1.3. Opportunities
      • 5.1.3.1. Rapid technological advancement in the field of pain-free drug transportation
      • 5.1.3.2. Introduction of technologically advanced products such as insulin pen, insulin pump, and other devices
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternative modes of drug delivery and requires sterility system maintenance
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Needle Free Drug Delivery Device Market, by Technology

  • 6.1. Introduction
  • 6.2. Inhaler Technology
  • 6.3. Jet Injectors
  • 6.4. Novel Needle-Free Technologies
  • 6.5. Oral Drug Delivery System
  • 6.6. Transdermal Patch Technology

7. Needle Free Drug Delivery Device Market, by Application

  • 7.1. Introduction
  • 7.2. Insulin Delivery for Diabetes
  • 7.3. Pain Management
  • 7.4. Pediatric Injections
  • 7.5. Vaccine Delivery

8. Americas Needle Free Drug Delivery Device Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Needle Free Drug Delivery Device Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Needle Free Drug Delivery Device Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. AkraDermojet Inc
  • 3. Antares Pharma Inc.
  • 4. Bayer AG
  • 5. Bioject Medical Technologies, Inc.
  • 6. Crossject
  • 7. Ferring B.V.
  • 8. GlaxoSmithKline plc
  • 9. Glide Pharmaceutical Technologies Ltd.
  • 10. InjexPharma AG
  • 11. MannKind Corporation
  • 12. Medtronic, Inc.
  • 13. Mika Medical Co.
  • 14. PenJet
  • 15. Zogenix, Inc.

LIST OF FIGURES

  • FIGURE 1. NEEDLE FREE DRUG DELIVERY DEVICE MARKET RESEARCH PROCESS
  • FIGURE 2. NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. NEEDLE FREE DRUG DELIVERY DEVICE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. NEEDLE FREE DRUG DELIVERY DEVICE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEEDLE FREE DRUG DELIVERY DEVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NEEDLE FREE DRUG DELIVERY DEVICE MARKET DYNAMICS
  • TABLE 7. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INHALER TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY JET INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY NOVEL NEEDLE-FREE TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY ORAL DRUG DELIVERY SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TRANSDERMAL PATCH TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INSULIN DELIVERY FOR DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY PEDIATRIC INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY VACCINE DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NEEDLE FREE DRUG DELIVERY DEVICE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 105. NEEDLE FREE DRUG DELIVERY DEVICE MARKET, FPNV POSITIONING MATRIX, 2023